| Literature DB >> 32270963 |
Abstract
OBJECTIVE: We aimed to compare the effectiveness of cognitive function protection between the standard follow-up parameters and advanced neuromonitoring methods in diabetic patients who underwent coronary artery bypass grafting during cardiopulmonary bypass.Entities:
Keywords: Cardiopulmonary Bypass; Cognitive Dysfunction; Coronary Artery Bypass; Diabetes Mellitus; Near-Infrared; Spectroscopy
Mesh:
Year: 2020 PMID: 32270963 PMCID: PMC7089738 DOI: 10.21470/1678-9741-2019-0160
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Fig. 1Algorithm for the treatment of cerebral desaturation.
FiO2=fraction of inspired oxygen; Hct=hematocrit; MAP=mean arterial pressure; PaCO2=partial carbon dioxide; rSO2=regional cerebral oxygenation
Description of demographic characteristics.
| Group 1 (n=24) | Group 2 (n=26) | ||
|---|---|---|---|
| Age (years) | 62±7.7 | 59.8±9.1 | 0.37 |
| Sex, n (%) | |||
| Male | 20 (83.3) | 4 (16.7) | 0.90 |
| Female | 22 (84.6) | 4 (15.4) | |
| Hypertension, n (%) | 13 (54.2) | 15 (57.7) | 0.80 |
| Hyperlipidemia, n (%) | 11 (45.8) | 9 (34.6) | 0.42 |
| Diabetes mellitus, n (%) | 10 (41.7) | 12 (46.2) | 0.75 |
| COPD, n (%) | 6 (25) | 0 (0) | 0.01 |
| CRF, n (%) | 2 (8.3) | 0 (0) | 0.13 |
| Smoking, n (%) | 9 (37.5) | 12 (46.2) | 0.54 |
| Ejection fraction, median (min-max) | 55 (40-65) | 55 (35-70) | 0.61 |
| PAD, n (%) | 3 (12.5) | 0 (0) | 0.06 |
| CVD, n (%) | 1 (4.2) | 0 (0) | 0.29 |
COPD=chronic obstructive pulmonary disease; CRF=chronic renal failure; CVD=cerebrovascular disease; PAD=peripheral artery disease
Intraoperative and postoperative data.
| Group 1 (n=24) | Group 2 (n=26) | ||
|---|---|---|---|
| Number of grafts (mean±SD) | 2.5±0.8 | 2.7±0.5 | 0.18 |
| CPB time, median (min-max) | 83 (40-217) | 89 (35-153) | 0.52 |
| AC time, median (min-max) | 45 (18-170) | 50 (15-108) | 0.65 |
| Temperature (°C), median (min-max) | 30 (28-34) | 30 (28-33) | 0.39 |
| Major neurological deficit, n (%) | 0 (0) | 0 (0) | 1.00 |
| Mortality, n (%) | 0 (0) | 0 (0) | 1.00 |
| Reoperation for bleeding, n (%) | 1 (4.2) | 1 (3.8) | 0.95 |
| ICU length of stay (days), median (min-max) | 3 (1-12) | 2 (1-8) | 0.04 |
| Length of hospital stay median (min-max) | 8 (6-28) | 7 (5-16) | <0.01 |
AC=aortic cross-clamp; CPB=cardiopulmonary bypass; ICU=intensive care unit
Comparison of cognitive functions between and in the groups.
| Comparison of preoperative cognitive results between groups | |||
|---|---|---|---|
| Mild cognitive decline, n (%) | 5 (20.8) | 6 (23.1) | 1.00 |
| Severe cognitive decline, n (%) | 0 (0) | 0 (0) | 1.00 |
| Mean MoCA score | 24.8±2.2 | 25.2±2.0 | 0.59 |
| Mild cognitive decline, n (%) | 13 (54.2) | 5 (19.2) | 0.02 |
| Severe cognitive decline, n (%) | 2 (8.3) | 0 (0) | 0.22 |
| Mean MoCA score | 23.6±2.6 | 26.0±2.3 | 0.001 |
| Group 1, Mean MoCA score | 24.8±2.2 | 23.6±2.6 | 0.02 |
| Group 2, Mean MoCA score | 25.2±2.0 | 26.0±2.3 | 0.06 |
MoCA=Montreal Cognitive Assessment
| Abbreviations, acronyms & symbols | ||||
|---|---|---|---|---|
| CABG | = Coronary artery bypass grafting | MoCA | = Montreal Cognitive Assessment | |
| CPB | = Cardiopulmonary bypass | NIRS | = Near-infrared spectroscopy | |
| DM | = Diabetes mellitus | O2Hb | = Oxyhemoglobin | |
| EAU | = Epiaortic ultrasound | PCO2 | = Partial carbon dioxide | |
| FiO2 | = Fraction of inspired oxygen | pO2 | = Partial oxygen | |
| Hb | = Hemoglobin | POCD | = Postoperative cognitive dysfunction | |
| HCT | = Hematocrit | rSO2 | = Regional cerebral tissue oxygenation | |
| HHb | = Deoxyhemoglobin | SPSS | = Statistical Package for the Social Sciences | |
| MAP | = Mean arterial blood pressure | TEE | = Transesophageal echocardiography | |
| Authors' roles & responsibilities | |
|---|---|
| HS | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| IK | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |